Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes
- PMID: 17959641
- DOI: 10.1183/09031936.00054507
Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes
Abstract
The aim of the present study was to investigate the prognostic value, in patients with community-acquired pneumonia (CAP), of procalcitonin (PCT) compared with the established inflammatory markers C-reactive protein (CRP) and leukocyte (WBC) count alone or in combination with the CRB-65 (confusion, respiratory rate >or=30 breaths x min(-1), low blood pressure (systolic value <90 mmHg or diastolic value <or=60 mmHg) and age >or=65 yrs) score. In total, 1,671 patients with proven CAP were enrolled in the study. PCT, CRP, WBC and CRB-65 score were all determined on admission and patients were followed-up for 28 days for survival. In contrast to CRP and WBC, PCT levels markedly increased with the severity of CAP, as measured by the CRB-65 score. In 70 patients who died during follow-up, PCT levels on admission were significantly higher compared with levels in survivors. In receiver operating characteristic analysis for survival, the area under the curve (95% confidence interval) for PCT and CRB-65 was comparable (0.80 (0.75-0.84) versus 0.79 (0.74-0.84)), but each significantly higher compared with CRP (0.62 (0.54-0.68)) and WBC (0.61 (0.54-0.68)). PCT identified low-risk patients across CRB classes 0-4. In conclusion, procalcitonin levels on admission predict the severity and outcome of community-acquired pneumonia with a similar prognostic accuracy as the CRB-65 score and a higher prognostic accuracy compared with C-reactive protein and leukocyte count. Procalcitonin levels can provide independent identification of patients at low risk of death within CRB-65 (confusion, respiratory rate >or=30 breaths x min(-1), low blood pressure (systolic value <90 mmHg or diastolic value <or=60 mmHg) and age >or=65 yrs) risk classes.
Similar articles
-
Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.BMC Infect Dis. 2007 Mar 2;7:10. doi: 10.1186/1471-2334-7-10. BMC Infect Dis. 2007. PMID: 17335562 Free PMC article.
-
Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia.Clin Chem Lab Med. 2015 Mar;53(4):559-66. doi: 10.1515/cclm-2014-0456. Clin Chem Lab Med. 2015. PMID: 25014522
-
Prognostic value of procalcitonin in community-acquired pneumonia.Eur Respir J. 2011 Feb;37(2):384-92. doi: 10.1183/09031936.00035610. Epub 2010 Jul 1. Eur Respir J. 2011. PMID: 20595156
-
[Biomarkers in community acquired pneumonia - what did we learn from the CAPNETZ study?].Pneumologie. 2011 Feb;65(2):110-3. doi: 10.1055/s-0030-1255935. Epub 2010 Nov 29. Pneumologie. 2011. PMID: 21117019 Review. German.
-
The role of procalcitonin in community-acquired pneumonia: a literature review.Adv Emerg Nurs J. 2012 Jul-Sep;34(3):259-71. doi: 10.1097/TME.0b013e318261338d. Adv Emerg Nurs J. 2012. PMID: 22842969 Review.
Cited by
-
Enhancing pneumonia prognosis in the emergency department: a novel machine learning approach using complete blood count and differential leukocyte count combined with CURB-65 score.BMC Med Inform Decis Mak. 2024 May 3;24(1):118. doi: 10.1186/s12911-024-02523-1. BMC Med Inform Decis Mak. 2024. PMID: 38702739 Free PMC article.
-
Diagnostic and prognostic value of deregulated long non-coding RNA RPPH1 in patients with severe community-acquired pneumonia: a retrospective cohort study.BMC Pulm Med. 2023 Jun 9;23(1):201. doi: 10.1186/s12890-023-02507-3. BMC Pulm Med. 2023. PMID: 37291525 Free PMC article.
-
Acute Infections and Inflammatory Biomarkers in Patients with Acute Pulmonary Embolism.J Clin Med. 2023 May 18;12(10):3546. doi: 10.3390/jcm12103546. J Clin Med. 2023. PMID: 37240652 Free PMC article.
-
Prognostic value of B-type natriuretic peptide for nursing- and healthcare-associated pneumonia and aspiration pneumonia in comparison with procalcitonin and A-DROP score: a prospective cohort study.Ann Transl Med. 2023 Mar 31;11(6):254. doi: 10.21037/atm-22-4151. Epub 2023 Feb 7. Ann Transl Med. 2023. PMID: 37082669 Free PMC article.
-
Clinical Utility of Procalcitonin on Antibiotic Stewardship: A Narrative Review.Infect Chemother. 2022 Dec;54(4):610-620. doi: 10.3947/ic.2022.0162. Infect Chemother. 2022. PMID: 36596677 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous